SMPD1 Gene: Sphingomyelin Phosphodiesterase 1 (Acid Sphingomyelinase)

Genetic insights into SMPD1: function, associated diseases, expression, and mutation landscape.

Gene Information Card

Symbol SMPD1
Full Name Sphingomyelin phosphodiesterase 1, acid lysosomal
Gene Type Protein coding
Chromosomal Location 11p15.4
NCBI Gene ID 6609 ncbi.nlm.nih.gov/gene/6609
Ensembl ID ENSG00000166311
UniProt ID P17405
OMIM ID 607608
HGNC ID 11120
Aliases ASM, ASMASE, NPD, SMPD1

Description

The SMPD1 gene encodes acid sphingomyelinase, a lysosomal enzyme that hydrolyzes sphingomyelin to ceramide and phosphocholine. This enzyme is critical for sphingolipid metabolism and cellular signaling. Mutations in SMPD1 lead to Niemann-Pick disease types A and B, characterized by lysosomal accumulation of sphingomyelin. The gene is also implicated in other conditions such as Parkinson's disease and certain cancers.

Disease Associations

Disease category Pathophysiological mechanism Genomic evidence
Niemann-Pick disease type A Loss-of-function mutations in SMPD1 result in deficient acid sphingomyelinase activity, leading to accumulation of sphingomyelin in lysosomes, particularly in macrophages and neurons. ClinVar, OMIM
Niemann-Pick disease type B Similar to type A but with residual enzyme activity, causing a milder phenotype with visceral involvement and less neurological impairment. ClinVar, OMIM
Parkinson's disease Heterozygous SMPD1 mutations are associated with increased risk of Parkinson's disease, possibly through altered ceramide metabolism and mitochondrial dysfunction. ClinVar, PubMed
Hepatocellular carcinoma Reduced SMPD1 expression or activity may contribute to tumor progression via dysregulated sphingolipid signaling. COSMIC, PubMed

Expression Profile

Tissue Expression
Tissue nTPM level
Liver 20.1 High
Spleen 15.3 High
Lung 10.2 Medium
Brain 8.5 Medium
Kidney 7.4 Medium
Heart 5.2 Low
Cell Line Expression
Cell Line nTPM Notes
HepG2 25.3 Liver cancer cell line, high expression
A549 12.1 Lung carcinoma, moderate expression
SH-SY5Y 9.8 Neuroblastoma, moderate expression
HeLa 6.4 Cervical carcinoma, low expression
Data source:Human Protein Atlas(proteinatlas.org)

Mutations & Variants

Hotspot Mutations
Variant Type Frequency Functional Description
p.Arg496Leu Missense Common in Niemann-Pick type A (Ashkenazi Jewish) Loss of enzyme activity
p.Leu302Pro Missense Found in Niemann-Pick type B Reduced enzyme activity
c.996delC Frameshift Rare, causes severe type A Loss of function
p.Phe333Ser Missense Associated with Parkinson's disease risk Partial loss of function
Mutation functional classification

Loss of Function (LOF)

Most SMPD1 mutations are loss-of-function, leading to reduced or absent acid sphingomyelinase activity, causing lysosomal sphingomyelin accumulation.

Gain of Function (GOF)

No gain-of-function mutations have been reported for SMPD1.

Dominant Negative (DN)

Some missense mutations may exert a dominant-negative effect when co-expressed with wild-type enzyme, but this is not well established.

Gene Ontology (GO)

• sphingomyelin phosphodiesterase activity • ceramide biosynthetic process
• lysosome • lipid catabolic process
• response to stress

Pathways

Sphingolipid metabolism
Sphingomyelin metabolism
Lysosome

Protein Summary

The SMPD1 protein is a lysosomal acid sphingomyelinase that catalyzes the hydrolysis of sphingomyelin to ceramide and phosphocholine. It is a glycoprotein that requires proteolytic processing for full activity. The enzyme plays a role in membrane turnover, apoptosis, and cell signaling. Defects in this protein lead to Niemann-Pick disease types A and B.

Related Products

Product name Cat.No. Species Gene ID
SMPD1 Knockout HEK293 Cell Line EDJ-KQ1740 Human 6609 Details Get a Quote
SMPD1 Knockout A-549 Cell Line EDJ-KQ21590 Human 6609 Details Get a Quote
SMPD1 Knockout HCT 116 Cell Line EDJ-KQ21591 Human 6609 Details Get a Quote
SMPD1 Knockout HeLa Cell Line EDJ-KQ21592 Human 6609 Details Get a Quote
SMPD1 Knockout Hep-G2 Cell Line EDJ-KZ482 Human 6609 Details Get a Quote
Displaying Records 1 To 5 Of 5 Records
Contact Us
*
*
*
*
How did you hear about us: